Key Influencer in the Anticoccidial Drugs Market 2025: Impact Of Growing Demand For Meat Proteins In The Anticoccidial Drug Market Driver

"What market dynamics are playing a key role in accelerating the growth of the anticoccidial drugs market?
The future progress of the anticoccidial drug market is anticipated to be driven by the increasing demand for meat proteins. These proteins, inherent in animal flesh, consist of crucial amino acids necessary for several body functions. This increased demand for meat proteins is due to factors like population growth, the rise in per capita income, urbanization, and shifting preferences towards protein-laden diets. Anticoccidial medications have become an integral element for successful livestock farming today as they ensure the health and efficiency of animals so that farmers can meet the escalating meat protein requirements effectively and sustainably. For instance, a report by the France-based intergovernmental organization, Organization for Economic Co-operation and Development (OECD), and the Food and Agriculture Organization, an Italy-based specialized agency, in July 2023 mentioned that relative to the expected 2% rise in the average global per capita meat demand from the 2020-2022 base period to 2032, there was a 10% spike in the FAO meat price index in 2022 because of lessened export supplies. Consequently, the increasing demand for meat proteins fuels the expansion of the anticoccidial drug market. The increasing adoption of poultry farming is predicted to be another significant factor driving the anticoccidial drug market's expansion. Poultry farming involves rearing domestic birds like chickens, turkeys, ducks, and geese, for meat, eggs, and feathers production. Increased protein demand, refined farming methods, and global trade expansion contribute to the increase in poultry farming. Anticoccidial medications are typically added to poultry feed or water as a protective step against coccidiosis during the early and most susceptible growth phases of the birds. For example, in June 2023, the US-based government establishment, USDA Economic Research Service, reported that the poultry sector's total sales in 2022 amounted to $76.9 billion, a significant 67% growth from the previous year. Thus, the surge in poultry farming fuels the anticoccidial drug market's growth.

Get Your Anticoccidial Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

How will the growth rate of the anticoccidial drugs market shape industry trends by 2034?
The market size of anticoccidial drugs has seen significant growth in the recent past. The forecast for this market indicates a rise from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth during the historic period include the global surge in cases of coccidiosis, higher adoption rates of pet animals, a high frequency of coccidiosis, its economic implications, and heightened safety concerns pertaining to the food and health of animals.

Expectations are high for significant expansion in the anticoccidial drugs market over the coming years, with projections suggesting a rise to $1.81 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.2%. This predicted growth throughout the forecast period is accredited to the development of veterinary healthcare, the increasing occurrence of coccidiosis in animals, the growing consumer demand for synthetic drugs and feed additives, along with greater livestock production. Dominant trends forecasted for the period are heightened demand due to new strains of coccidiosis, an industry shift towards more natural and alternative treatments, a surge of innovation inspired by an increase in regulatory scrutiny, a customer preference trend towards poultry products free from antibiotics, breakthroughs in drug delivery technologies, an intensified emphasis on preventive healthcare and an expansion into the aquaculture and pet sectors.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

What trends are poised to drive the future success of the anticoccidial drugs market?
Major players in the anticoccidial drugs market are placing emphasis on the creation of original solutions, for instance, synthetic coccidiostat, to heighten effectiveness, diminish the evolution of resistance, and tackle rising issues in poultry and livestock management. Synthetic coccidiostat, a chemically structured compound, functions by obstructing the growth and reproduction of coccidia parasites in animals. For example, in March 2023, Zoetis, an animal health firm based in the US, released Avi-Deccox, a revamped synthetic coccidiostat created to manage coccidiosis in broiler chickens. This novel product intentionally combats the Eimeria acervulina and Eimeria tenella pathogens, both known to cause substantial financial losses in poultry farming. The innovative product employs decoquinate, akin to its forerunner, Deccox, as its primary ingredient. Avi-Deccox responds to the amplified issue of resistance related to the habitual utilization of ionophores in poultry farming by executing a distinct mode of action, offering a highly effective short-term suppressive effect.

Which primary segments of the anticoccidial drugs market are driving growth and industry transformations?
The anticoccidial drugs market covered in this report is segmented -

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

Which geographical regions are pioneering growth in the anticoccidial drugs market?
North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the anticoccidial drugs market landscape?
Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

What Is Covered In The Anticoccidial Drugs Global Market Report?

•Market Size Forecast: Examine the anticoccidial drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the anticoccidial drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the anticoccidial drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the anticoccidial drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the anticoccidial drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the anticoccidial drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the anticoccidial drugs market.
•Competitive Landscape: Review strategic developments in the anticoccidial drugs market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.